Czechia· CZ-0224145

ULCAMED

A bismuth subcitrate product containing bismuth subcitrate, registered in Czechia by Krka, d.d., Novo mesto, Novo mesto. The same ATC class is registered in 3 of our 19 countries.

ATC A02BX05

Checked against SÚKL (Czech Republic) on

Informational only — not a medical device.

SOURCE REGISTER · CZSÚKL (Czech Republic)normalisedULCAMEDATCA02BX05REGISTER NO.CZ-0224145PACKS LISTED0CHECKEDSeptember 28, 2026

Where it is registered

Bismuth subcitrate is registered in 3 of 19 countries.

Countries holding a registration under ATC A02BX05 (bismuth subcitrate), each read from that country’s own register.

  • This record: Czechia, from SÚKL (Czech Republic)
  • 3 of them publish a price we can compare per daily dose

Bismuth subcitrate · ATC A02BX05

3 / 19 countries

  • Czechiaprice
  • Finlandprice
  • Polandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

SÚKL (Czech Republic)
Active substance
BISMUTH SUBCITRATE
Manufacturer
Krka, d.d., Novo mesto, Novo mesto
Country
Czechia (CZ)
ATC code
A02BX05
ATC class
Bismuth subcitrate
Defined daily dose
0.48 g, O
Reimbursed
Not published by this register
Source register
SÚKL (Czech Republic)
Last checked
September 28, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

4 interactions on record for bismuth subcitrate.

Graded by severity as the source publishes them — 4 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Bismuth subcitrate · interactions on record

4 records

  • 4 moderate

Most severe, free to view

  • DemeclocyclineJ01AA01moderate
  • DoxycyclineJ01AA02moderate
  • TetracyclineJ01AA07moderate
  • MinocyclineJ01AA08moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Bismuth subcitrate in 2 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All bismuth subcitrate products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of SÚKL (Czech Republic). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/da07d7a6-23cb-4313-9b6f-89ef6c5a8063
GET /v1/drugs/da07d7a6-23cb-4313-9b6f-89ef6c5a8063?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "TBL FLM",
  "source": "sukl",
  "strength": "120MG",
  "pack_size": "30",
  "substance": "BISMUTH SUBCITRATE",
  "cz_kod_sukl": "0224145",
  "product_type": "CH",
  "substance_codes": "4323",
  "registration_state": "R",
  "registration_number": "09/308/17-C"
}

See everything about bismuth subcitrate.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.